Kenneth F. Miller

BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA.

R2 Technology, Inc. develops and commercializes computer aided detection (CAD). The company also offers CAD systems for a variety of imaging modalities and disease states. The firm was founded in May, 1993 by S.P. Bob Wang and is headquartered in Santa Clara, CA.

BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA.

CareFusion 303, Inc. designs, makes and distributes infusion therapy and vital signs measurement instruments. The company operates manufacturing facilities in the United States, Mexico and the United Kingdom. The firm was founded in 1988 and is headquartered in San Diego, CA.

CareFusion 303, Inc. designs, makes and distributes infusion therapy and vital signs measurement instruments. The company operates manufacturing facilities in the United States, Mexico and the United Kingdom. The firm was founded in 1988 and is headquartered in San Diego, CA.

CareFusion 303, Inc. designs, makes and distributes infusion therapy and vital signs measurement instruments. The company operates manufacturing facilities in the United States, Mexico and the United Kingdom. The firm was founded in 1988 and is headquartered in San Diego, CA.

R2 Technology, Inc. develops and commercializes computer aided detection (CAD). The company also offers CAD systems for a variety of imaging modalities and disease states. The firm was founded in May, 1993 by S.P. Bob Wang and is headquartered in Santa Clara, CA.

R2 Technology, Inc. develops and commercializes computer aided detection (CAD). The company also offers CAD systems for a variety of imaging modalities and disease states. The firm was founded in May, 1993 by S.P. Bob Wang and is headquartered in Santa Clara, CA.

R2 Technology, Inc. develops and commercializes computer aided detection (CAD). The company also offers CAD systems for a variety of imaging modalities and disease states. The firm was founded in May, 1993 by S.P. Bob Wang and is headquartered in Santa Clara, CA.

BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA.

BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA.

BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA.

BioVentrix, Inc. engages in development of medical devices. It offers Less Invasive Ventricular Enhancement, or the LIVE therapy, which uses the Revivent TC transcatheter ventricular enhancement system to exclude scar tissue on the left ventricle that has occurred from a heart attack. The company was founded by Arthur A. Bertolero and Lon S. Annest in 2003 and is headquartered in San Ramon, CA.